✦ LIBER ✦

Treatment of chronic hepatitis C: Anticipated impact of resistance in patients treated with protease inhibitors

✍ Scribed by Bernd Kronenberger; Stefan Zeuzem

Book ID: 107538460
Publisher: Springer
Year: 2009
Tongue: English
Weight: 432 KB
Volume: 11
Category: Article
ISSN: 1522-8037
DOI: 10.1007/s11894-009-0003-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Resistance-Associated Variants in Chroni

Resistance-Associated Variants in Chronic Hepatitis C Patients Treated with Protease Inhibitors

✍ Maya Gambarin-Gelwan; Ira M. Jacobson 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 149 KB

Efficacy and safety of telaprevir, a new

Efficacy and safety of telaprevir, a new protease inhibitor, for difficult-to-treat patients with genotype 1 chronic hepatitis C

✍ N. Hayashi; T. Okanoue; H. Tsubouchi; J. Toyota; K. Chayama; H. Kumada 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

Characterization of resistance to the pr

Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus–infected patients

✍ Simone Susser; Christoph Welsch; Yalan Wang; Markus Zettler; Francisco S. Doming 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 543 KB

Boceprevir is a hepatitis C virus (HCV) nonstructural protein (NS) 3/4A protease inhibitor that is currently being evaluated in combination with peginterferon alfa-2b and ribavirin in phase 3 studies. The clinical resistance profile of boceprevir is not characterized in detail so far. The NS3 protea

Prevalence and impact of occult hepatiti

Prevalence and impact of occult hepatitis B infection in chronic hepatitis C patients treated with pegylated interferon and ribavirin

✍ Marion Levast; Sylvie Larrat; Marie-Ange Thelu; Sandrine Nicod; Agnès Plages; Al 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

## Abstract The prevalence of occult hepatitis B, defined by absence of HBsAg and HBV DNA, ranges widely in patients with hepatitis C. This may influence the treatment of hepatitis C and the severity of liver disease. Sensitive and specific real‐time PCR techniques are available commercially and ca

Detection of hepatitis C virus RNA in se

Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-α

✍ Hideki Hagiwara; Norio Hayashi; Eiji Mita; Keiji Ueda; Tetsuo Takehara; Akinori 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 532 KB

We tested serial serum samples for hepatitis C virus RNA from patients undergoing treatment for chronic hepatitis C with interferon-a using an assay that combined reverse transcription and polymerase chain reaction. The subjects studied were 20 patients with chronic hepatitis who had serum antibody

Ciclosporin treatment of psoriasis in a

Ciclosporin treatment of psoriasis in a patient with chronic hepatitis C

✍ S. Imafuku; A. Tashiro; M. Furue 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 269 KB